From a geographic perspective, Emerging Markets was the only region to generate organic growth in 2012, driven by Cebion®, the Consumer Health vitamin C brand. In Europe, top-line sales were negatively affected by the refocus on strategic brands as well as restructuring efforts. In addition, the division faced declining over-the-counter medicines markets and strong competitive pressure in Central Europe. The sales decline in North America reflects the market exit of Consumer Health in Canada.
Consumer Health | Sales by region – 2012
| XLS |
|
Consumer Health | Sales growth components by region – 2012 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million / change in % |
Sales |
Organic |
Exchange |
Acquisitions / divestments |
Reported |
|
Europe |
315.1 |
–8.5 |
1.0 |
– |
–7.5 |
|
North America |
1.2 |
–75.1 |
1.3 |
– |
–73.7 |
|
Emerging Markets |
139.4 |
2.2 |
4.3 |
– |
6.5 |
|
Rest of World |
16.9 |
–4.9 |
–2.0 |
– |
–6.9 |
|
World in total |
472.5 |
–6.2 |
1.8 |
– |
–4.4 |
back
